Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Kenji TsuchihashiMamoru ItoYuta OkumuraKenta NioYukinori OzakiHiroshi NishioEiki IchiharaYuji MiuraMakoto EndoShingo YanoDai MaruyamaTetsuhiro YoshinamiNobuyuki SusumuMunetaka TakekumaTakashi MotohashiNobuaki OchiToshio KuboKeita UchinoTakahiro KimuraYutaro KamiyamaShinji NakaoShinobu TamuraHitomi NishimotoYasuhisa KatoAtsushi SatoToshimi TakanoEishi BabaPublished in: International journal of clinical oncology (2024)
A weak recommendation is made that G-CSF treatment not be administered to patients with febrile neutropenia during cancer chemotherapy. G-CSF treatment can be considered for patients at high risk.